-
-
Call more information
660-596-2224 -
Author: Christian S. Guay, MD International Anesthesia Reserach Society The Daily Dose April 2023 With the release of ChatGPT in November 2022, artificial intelligence (AI) has quickly become one of the most popular topics for mainstream headlines and social media. This transformative technology is quickly spreading through multiple industries, including healthcare, where AI has been […]
Read MoreAuthors: John C. Klick, MD, FCCP, FASE, FCCM; Linda W. Young, MD, MS ASA Monitor April 2023, Vol. 87, 30. Lessons learned from the ICU translate directly into anesthetic care of critically ill patients in the OR and NORA locations. Critically ill patients presenting to the OR are at high risk and present with issues that require […]
Read MoreAuthor: Helen Olkaba, MS ASA Monitor April 2023, Vol. 87, 31. Effective March 12, 2023, Cigna will reduce payment on services reported with modifier QZ by 15%. Modifier QZ identifies services provided by CRNAs without medical direction of a physician. According to Cigna, this was done to align payment with other advanced practice providers (e.g., nurse […]
Read MoreAuthor: Gundappa Neelakanta, MBBS ASA Monitor April 2023, Vol. 87, e4. “Here comes your margarita!” I hear the familiar words through the thin walls of the cubicle in the preoperative area as I talk to my patient on the other side of the cubicle. Their conversation then turned to, “It’s never too early for a drink” […]
Read MoreASA Monitor April 2023, Vol. 87, 12. The juvenile form of Pompe disease is MOST often associated with which of the following clinical abnormalities? □ (A) Micrognathia □ (B) Hypertrophic cardiomyopathy □ (C) Hypertonia Pompe disease is a disorder of carbohydrate metabolism and one of several glycogen storage diseases. The defective enzyme (acid α-glucosidase) impedes the breakdown of glycogen […]
Read More